A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/704 (2006.01) A61K 9/00 (2006.01) A61K 9/70 (2006.01) A61K 31/341 (2006.01) A61K 47/30 (2006.01) A61P 31/20 (2006.01)
Patent
CA 2621200
A transdermal active principle delivery means comprises a skin adherent or otherwise skin - tolerant substrate applicable to a skin, area affected by DNA virus, which substrate includes a composition for treating DNA comprising a transdermally effective carrier medium including at least one active principle selected from the group consisting of diuretic agents and/or cardiac glycoside agents.
L'invention concerne des moyens d'administration transdermique de principes actifs comprenant un substrat adhérant à la peau ou tolérant pour la peau à appliquer sur une zone de la peau touchée par le virus à ADN, le substrat comprenant une composition permettant de traiter l'ADN présentant un milieu d'excipient efficace sur le plan transdermique comprenant au moins un principe actif sélectionné dans le groupe comprenant des agents diurétiques et/ou des agents de glycoside cardiaque.
Hartley Christopher
Pardoe Ian Stuart
Henderson Morley Plc
Robic
LandOfFree
Transdermal active principle delivery means does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal active principle delivery means, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal active principle delivery means will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1745149